Nutex Health (NUTX)
(Delayed Data from NSDQ)
$5.05 USD
+0.28 (5.87%)
Updated Jul 12, 2024 04:00 PM ET
After-Market: $4.90 -0.15 (-2.97%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMBalance Sheet
Fiscal Year End for Nutex Health Inc falls in the month of December.
All items in Millions except Per Share data.
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 22 | 34 | 15 | 0 | 1 |
Receivables | 63 | 58 | 2 | 0 | 0 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 3 | 4 | 0 | 0 | 0 |
Other Current Assets | 3 | 2 | 0 | 0 | 0 |
Total Current Assets | 91 | 98 | 18 | 0 | 1 |
Net Property & Equipment | 81 | 82 | 0 | 0 | 0 |
Investments & Advances | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 0 | 0 | 0 | 0 | 0 |
Intangibles | 38 | 38 | 68 | 0 | 5 |
Deposits & Other Assets | 0 | 0 | 0 | 0 | 0 |
Total Assets | 398 | 432 | 86 | 0 | 7 |
Liabilities & Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 1 | 0 | 2 |
Accounts Payable | 25 | 28 | 4 | 1 | 2 |
Current Portion Long-Term Debt | 14 | 15 | 4 | 0 | 0 |
Current Portion Capital Leases | 4 | 4 | 0 | 0 | 0 |
Accrued Expenses | 13 | 6 | 0 | 0 | 0 |
Income Taxes Payable | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 0 | 0 | 0 | 0 | 0 |
Total Current Liabilities | 58 | 55 | 9 | 1 | 5 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 5 | 10 | 2 | 0 | 0 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 26 | 23 | 0 | 0 | 0 |
Non-Current Capital Leases | 214 | 204 | 0 | 0 | 0 |
Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 319 | 311 | 11 | 1 | 5 |
Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 1 | 1 | 0 | 0 | 0 |
Capital Surplus | 470 | 459 | 107 | 17 | 14 |
Retained Earnings | -409 | -363 | -32 | -18 | -13 |
Other Equity | 18 | 24 | 0 | 0 | 0 |
Treasury Stock | 0 | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | 79 | 120 | 75 | -1 | 2 |
Total Liabilities & Shareholder's Equity | 398 | 432 | 86 | 0 | 7 |
Total Common Equity | 79 | 120 | 75 | -1 | 2 |
Shares Outstanding | 4.40 | 4.30 | 0.30 | 0.00 | 0.00 |
Book Value Per Share | 17.98 | 27.98 | 250.47 | -1.13 | 1.86 |
Fiscal Year End for Nutex Health Inc falls in the month of December.
All items in Millions except Per Share data.
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | -99,999 | 30 | 22 | 27 | 33 |
Receivables | NA | 66 | 63 | 55 | 52 |
Notes Receivable | NA | 0 | 0 | 0 | 0 |
Inventories | NA | 3 | 3 | 3 | 2 |
Other Current Assets | NA | 2 | 3 | 6 | 5 |
Total Current Assets | NA | 100 | 91 | 90 | 92 |
Net Property & Equipment | NA | 81 | 81 | 86 | 83 |
Investments & Advances | NA | 0 | 0 | 0 | 0 |
Other Non-Current Assets | NA | 0 | 0 | 0 | 0 |
Deferred Charges | NA | 0 | 0 | 0 | 0 |
Intangibles | NA | 37 | 38 | 40 | 37 |
Deposits & Other Assets | NA | 1 | 0 | 0 | 0 |
Total Assets | NA | 404 | 398 | 480 | 436 |
Liabilities & Shareholders Equity | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 |
---|---|---|---|---|---|
Notes Payable | NA | 0 | 0 | 0 | 0 |
Accounts Payable | NA | 24 | 25 | 24 | 32 |
Current Portion Long-Term Debt | NA | 12 | 14 | 23 | 19 |
Current Portion Capital Leases | NA | 4 | 4 | 4 | 4 |
Accrued Expenses | NA | 18 | 13 | 15 | 0 |
Income Taxes Payable | NA | 0 | 0 | 0 | 0 |
Other Current Liabilities | NA | 0 | 0 | 0 | 0 |
Total Current Liabilities | NA | 60 | 58 | 67 | 57 |
Mortgages | NA | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | NA | 5 | 5 | 8 | 9 |
Convertible Debt | NA | 0 | 0 | 0 | 0 |
Long-Term Debt | NA | 26 | 26 | 19 | 25 |
Non-Current Capital Leases | NA | 213 | 214 | 264 | 220 |
Other Non-Current Liabilities | NA | 0 | 0 | 0 | |
Minority Interest (Liabilities) | NA | 0 | 0 | 0 | 0 |
Total Liabilities | NA | 324 | 319 | 375 | 328 |
Shareholders Equity | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 |
---|---|---|---|---|---|
Preferred Stock | NA | 0 | 0 | 0 | 0 |
Common Stock (Par) | NA | 0 | 1 | 1 | 1 |
Capital Surplus | NA | 472 | 470 | 467 | 464 |
Retained Earnings | NA | -409 | -409 | -377 | -372 |
Other Equity | NA | 17 | 18 | 15 | 16 |
Treasury Stock | NA | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | NA | 80 | 79 | 105 | 108 |
Total Liabilities & Shareholder's Equity | NA | 404 | 398 | 480 | 436 |
Total Common Equity | 0 | 80 | 79 | 105 | 108 |
Shares Outstanding | 4.90 | 4.90 | 4.40 | 4.40 | 4.30 |
Book Value Per Share | 0.00 | 16.33 | 17.98 | 23.84 | 25.17 |